SARS-CoV 2 Clinical Trial
Official title:
COVID-19 Serology in Nephrology Health Care Workers
Infections with Corona-Viruses have shown to be a menace for patients with comorbidities such
as hypertension, diabetes, cardiovascular disease or immunosuppression. Those are features
almost every nephrological patient brings along, especially those on maintenance dialysis and
those with renal transplant. Since the emergence of the novel coronavirus SARS-CoV-2 in
November 2019 in Mainland China the fear for pandemic infections has increased. But not only
is the course of infection itself important, the prevention of transmission to and by
attending medical personnel should be put into perspective. Thus there is a lack of
sufficient data of occult immunization or persistent state on immunization.
In our study up to 400 health care personnel will be screened serologically for IgM, IgA and
IgG against the SARS-CoV-2 virus. Blood and urine samples throughout 12 months will be
sampled and analyzed.
The aim of the study is to identify the rate of occult immunization and at the same time to
gather data about the persistence of immune response to an infection with SARS-CoV-02. The
results will help provide sufficient safety measures for health care providers and renal
patients undergoing unavoidable clinical treatment.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04410510 -
P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19
|
Phase 2/Phase 3 | |
| Withdrawn |
NCT04456426 -
Characteristics of Patients With COVID-19 in Meta State, Colombia
|
||
| Terminated |
NCT04435457 -
Cardiovascular Implications of COVID-19
|
||
| Suspended |
NCT04385771 -
Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation
|
N/A | |
| Withdrawn |
NCT04386447 -
Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19
|
Phase 2 | |
| Completed |
NCT04357834 -
WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories
|
||
| Completed |
NCT04405934 -
COG-UK Project Hospital-Onset COVID-19 Infections Study
|
N/A | |
| Completed |
NCT04615936 -
Nasal Photodisinfection COVID-19 Proof of Concept Study
|
N/A | |
| Completed |
NCT04369794 -
COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement
|
Phase 4 | |
| Terminated |
NCT04401410 -
Anti-SARS Cov-2 T Cell Infusions for COVID 19
|
Phase 1 | |
| Completed |
NCT04542850 -
Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19
|
N/A | |
| Completed |
NCT04382040 -
A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19
|
Phase 2 | |
| Completed |
NCT04366908 -
Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome
|
Phase 2 | |
| Completed |
NCT04378582 -
Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU
|
||
| Completed |
NCT04383587 -
Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers
|
N/A | |
| Recruiting |
NCT04402814 -
IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.
|
||
| Completed |
NCT04374565 -
Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia
|
Phase 2 | |
| Completed |
NCT04395924 -
Maternal-foetal Transmission of SARS-Cov-2
|
||
| Completed |
NCT04425889 -
COVID-19 Antibodies Among Healthcare Workers
|
||
| Completed |
NCT04413071 -
Cardiac COVID-19 Health Care Workers
|